Oligodendrogenesis from neural stem cells: Perspectives for remyelinating strategies
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Mobilization of remyelinating cells spontaneously occurs in the adult brain. These cellular resources are specially active after demyelinating episodes in early phases of multiple sclerosis (MS). Indeed, oligodendrocyte precursor cells (OPCs) actively proliferate, migrate to and repopulate the lesioned areas. Ultimately, efficient remyelination is accomplished when new oligodendrocytes reinvest nude neuronal axons, restoring the normal properties of impulse conduction. As the disease progresses this fundamental process fails. Multiple causes seem to contribute to such transient decline, including the failure of OPCs to differentiate and enwrap the vulnerable neuronal axons. Regenerative medicine for MS has been mainly centered on the recruitment of endogenous self‐repair mechanisms, or on transplantation approaches. The latter commonly involves grafting of neural precursor cells (NPCs) or neural stem cells (NSCs), with myelinogenic potential, in the injured areas. Both strategies require further understanding of the biology of oligodendrocyte differentiation and remyelination. Indeed, the success of transplantation largely depends on the pre‐commitment of transplanted NPCs or NSCs into oligodendroglial cell type, while the endogenous differentiation of OPCs needs to be boosted in chronic stages of the disease. Thus, much effort has been focused on finding molecular targets that drive oligodendrocytes commitment and development. The present review explores several aspects of remyelination that must be considered in the design of a cell‐based therapy for MS, and explores more deeply the challenge of fostering oligodendrogenesis. In this regard, we discuss herein a tool developed in our research group useful to search novel oligodendrogenic factors and to study oligodendrocyte differentiation in a time‐ and cost‐saving manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991 · cited 2×
“…molecules in OPCs migration during development and in active MS lesions; (b) quiescence of available OPCs in the lesion site, being unable to differentiate (Wolswijk, 1998); (c) or failure of the available and mature oligodendrocytes to accomplish remyelination of axons (Chang et al., 2002).”
BackgroundMatsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984 · cited 4×
“CPZ toxicity leads to the degeneration of oligodendrocytes, and consequent disruption of myelin, followed by microgliosis and astrogliosis in the demyelinated tracts (Hiremath et al., 1998; Koutsoudaki et al., 2009; Matsushima and Morell, 2001; Skripuletz et al., 2008).”
BackgroundInfluentialOrigin of oligodendrocytes in the subventricular zone of the adult brain
Menn, B., Garcia-Verdugo, J. M., Yaschine, C., Gonzalez-Perez, O., Rowitch, D., & Alvarez-Buylla, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1299-06.2006 · Cited by 972 · cited 4×
“Importantly, SVZ-derived oligodendrocytes undergo all the developmental stages from the early OPCs to the mature myelinating oligodendrocytes recapitulating the developmental process (Levison and Goldman, 1993; Menn et al., 2006) and are able to remyelinate axons in animal models of demyelinating injuries (Akiyama et…”
BackgroundInfluentialSim, F. J., Zhao, C., Penderis, J., & Franklin, R. J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02451.2002 · Cited by 625
Wolswijk, G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00601.1998 · Cited by 562
Nait‐Oumesmar, B., Decker, L., Lachapelle, F., Avellana‐Adalid, V., Bachelin, C., & Van Evercooren, A. B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00873.x · Cited by 560 · cited 1×
“SVZ-derived cells expand and migrate to the nearby corpus callosum, undergo oligodendrogenesis (Nait-Oumesmar et al., 1999; Picard-Riera et al., 2002), acquiring morphology of myelinating cells and express myelin proteins (Menn et al., 2006).”
BackgroundMicroglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice
Hiremath, M. M., Saito, Y., Knapp, G. W., Ting, J. P.-Y., Suzuki, K., & Matsushima, G. K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00168-4 · Cited by 459 · cited 1×
“CPZ toxicity leads to the degeneration of oligodendrocytes, and consequent disruption of myelin, followed by microgliosis and astrogliosis in the demyelinated tracts (Hiremath et al., 1998; Koutsoudaki et al., 2009; Matsushima and Morell, 2001; Skripuletz et al., 2008).”
BackgroundWoodruff, R. H., Fruttiger, M., Richardson, W. D., & Franklin, R. J. M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.10.014 · Cited by 335
Cortical Demyelination Is Prominent in the Murine Cuprizone Model and Is Strain-Dependent
Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., Trebst, C., & Stangel, M. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070850 · Cited by 271 · cited 2×
“CPZ toxicity leads to the degeneration of oligodendrocytes, and consequent disruption of myelin, followed by microgliosis and astrogliosis in the demyelinated tracts (Hiremath et al., 1998; Koutsoudaki et al., 2009; Matsushima and Morell, 2001; Skripuletz et al., 2008).”
Background
Cited by
Glial Cells and Integrity of the Nervous System
von Bernhardi, R., Eugenín-von Bernhardi, J., Flores, B., & Eugenín León, J. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-40764-7_1 · Cited by 67
Jiang, Y., Wang, Y., Sun, Y., & Jiang, H. (2020) · PLOS ONE · doi:10.1371/journal.pone.0243644 · Cited by 24
Scalabrino, G. (2022) · Biomedicines · doi:10.3390/biomedicines10040815 · Cited by 10
Metadata
- Authors
- Grade, S., Bernardino, L., & Malva, J. O.
- Venue
- International Journal of Developmental Neuroscience
- Publisher
- Wiley
- Published
- 2013-01-19
- Volume
- 31
- Issue
- 7
- Pages
- 692-700
- ISSN
- 0736-5748 (ISSN-L)
- 1873-474X
- OpenAlex
- W2073069613
- Cited by
- 54
- References
- 16
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.